A study on siddha trial drug Rajaloga naatharasa parpam(Int) Paruthi thylam(Ext) and Ottradam(External therapy) in patients having joints pain

An open clinical evaluation on Uthiravadha suronitham(Rheumatoid arthritis) with siddha trial drug Rajaloga naatharasa parpam(Int),Paruthi thylam (Ext) and ottradam (Therapy)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013640

Enrollment

Registered

2018-05-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Uthiravadha suronitham(Rheumatoid arthritis)

Interventions

Intervention1: Rajaloga naatharasa parpam(Int) and Paruthi thylam (Ext): 20 patients treated with Rajaloga naatharasa parpam 60 mg twice daily internal,Paruthi thylam external application for 21 days.

Eligibility

Inclusion criteria

Inclusion criteria: 1.Low grade fever 2.Morning stiffness >1hours 3.Arthritis of >=3 joint area of the possible 28 joints 4.Arthritis of hand joints[MCPs , PIPs , WRISTs] 5.Symmetric swelling â??same joints on both sides 6.Redness of joints 7.Rheumatoid nodules 8.Serum rheumatoid factor[RA factor]+ve or -ve 9.Anti ccp +ve

Exclusion criteria

Exclusion criteria: 1.Systemic lupus erythematosis 2.Sub acute bacterial endocarditis 3.Rheumatic fever 4.Gouty arthritis 5.Carries spine 6.Ankylosing spondylitis 7.Psoriatic arthritis 8.Osteomyelitis 9.Renal failure 10.Tumours 11.History of long term intake of steroid 12.HIV 13.Progressive systemic sclerosis 14.Pregnancy&lactation 15.Chickungunya

Design outcomes

Primary

Measure	Time frame
1.Primary outcome is mainly assessed by reduction in pain and inflammation of joints 2.Reduction of morning stiffness 3.Pain is assessed by universal pain assessment scale 4.By comparing the any two parameters before and after treatment ESR, Hb, Anti-CCP, RA factor,CRP Timepoint: 12 months	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDrDSuganya

Government Siddha Medical College

guidesaibudeen@gmail.com9486041993

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026